Online Pharmacy Can Fill Prescriptions After Testing Your Drugs For Purity and Safety

Online drug testing pharmacy Valisure is the first and only, to my knowledge, online drug testing pharmacy

Monday, February 22, 2021 - If you purchase medicines over the counter that have been sitting on the shelves of Rite Aid, Walmart, or CVS, you should pay close attention to their expiration date. Zantac was recalled in 2020, as were other forms of ranitidine when the FDA was informed of potentially carcinogenic levels of the compound in Zantac and other tablets. Thousands of individuals with cancer, allegedly caused by taking Zantac, have registered to file lawsuits against Sanofi on those grounds, and the first bellwether trials may start this spring. Lawsuits allege that Sanofi, the maker of Zantac, should be held accountable for knowing about the cancer risk of NDMA and that they had the responsibility for warning their customers.

Scientists think the reason Zantac becomes contaminated with NDMA is that ranitidine is an inherently unstable compound subject to degrading due to high temperatures or its interaction with stomach acid. Consumers assume the drugs they take have been FDA tested and approved and are safe, and at first, they may have been. But until recently, there was no mechanism in place to test drugs that could be sitting on shelves. There is also no way to know what other dangerous drugs may be sitting on drug stores and retail shelves. Consumers can fill their prescriptions online and have their specific product tested for purity, freshness, and safety. If you or a loved one have taken Zantac regularly for over a year and have developed cancer of the stomach, bladder, esophagus, or other cancer, you should speak with a Zantac cancer lawyer to see if you qualify to file a claim.

Online drug testing pharmacy Valisure is the first and only, to my knowledge, online drug testing pharmacy. Valisure was the independent laboratory that found elevated levels of NDMA in Zantac tablets and immediately alerted Sanofi, who voluntarily recalled the drug. The FDA issued a recall one month later. Valisure has also found NDMA acceleration and contamination in tablets used to treat high blood pressure and diabetes. Valisure had found levels of carcinogenic NDMA thousands of times higher than the 96 NGS that the FDA had deemed safe.

The Valisure Zantac revelations have sparked not only a tsunami of lawsuits against Sanofi but also many laboratories are now performing scientific testing to make sure Valisure is on target. Studies performed by accredited scientific independent laboratories back Valisure's findings. According to EcoWatch, "In a new study in JAMA Network Open, investigators simulated the stomach environment and found that when ranitidine was exposed to an acidic environment with a nitrite source, these chemicals could create more than 10,000 ng of NDMA. These results support a clinical study in which urine samples were collected from 10 adults both before and after using ranitidine. After people swallowed ranitidine, the urinary NDMA doses rose from about 100 ng to more than 40,000 ng over the next day."

More Recent Heartburn MedicineLawsuit News:

• Zantac Cancer Trials Are In Discovery To Begin In October 2022 | 7/19/2022
• Zantac Cancer Lawsuits Could Hinge On The Validity of Ranitidine Testing Methods | 7/11/2022
• Zantac Cancer Bellwether Trials In California Could Set The Stage For A Global Settlement Offer | 7/5/2022
• The FDA Recommended Protein Pump Inhibitor Drugs Like Prilosec And Nexium That May Damage Health More Than Zantac | 6/23/2022
• Truck Drivers, Firefighters, and Police Officers May Have Taken More Zantac Than People In Other Occupations | 6/20/2022
• Scientists Are Expected To Confirm That Ranidine Causes Gastrointestinal Cancer With Slam Dunk Testimony | 6/9/2022
• Scientific Hearings Will Start This September To Interview Zantac Cancer Expert Witnesses | 5/19/2022
• A Whistleblower Scientist Working For A Chinese Company Thinks NDMA Contamination Started In China | 5/12/2022
• Valisure's String Of Stunning Success Casts Doubt On The FDAs Ability To Police The Health Care Market | 5/2/2022
• Zantac Testing Accusations Heat Up With FDA Investigation Of Online Prescription Drug Testing Lab | 4/25/2022
• Study Finds Ranitidine Degrades Into 10,000 Nanograms of NDMA When Introduced To Simulated Stomach Conditions | 4/6/2022
• Potential Zantac Expert Witnesses Are Being Questioned By Zantac Defense Attorneys | 3/31/2022
• The FDA Requires That Drug Companies Regularly Test Ranitidine And Other Drug For NDMA | 3/24/2022
• Update: Where The Zantac Cancer Multidistrict Litigation (MDL) Stands Today | 3/12/2022
• Zantac Cancer Plaintiffs Look To The First Trial In October In Alameda California | 3/11/2022
• Zantac Cancer Plaintiffs Have Until June 30 To Finalize Their Claim | 3/7/2022
• Zantac Bellwether Trials May Focus On Ranitidine Testing Methods That Could Cause NDMA To Accelerate | 3/1/2022
• Valisure LLC's Motivations And Ranitidine Testing Methods May Not Be Scrutinized Before Trial | 2/24/2022
• Zantac Lawsuits May Go To Trial In California In October Of This Year | 2/18/2022
• Sanofi's History Of Reprehensible Corporate Behavior May Bolster Zantac Cancer Lawsuits | 2/10/2022

Lawyers for Zantac Heartburn Medicine Lawsuits

OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The Onder Law Firm has won more than $300 million in four talcum powder ovarian cancer lawsuits in St. Louis. Law firms throughout the nation often seek its experience and expertise on complex litigation.